Literature DB >> 4609635

Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.

W H Frishman, B Weksler, J P Christodoulou, C Smithen, T Killip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609635     DOI： 10.1161/01.cir.50.5.887

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  22 in total

1.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 3.  Profile of an ideal antianginal agent.

Authors:  E J Lazar; W H Frishman
Journal:  Drugs       Date:  1989       Impact factor: 9.546

4.  Antiplatelet effects of oral diltiazem, propranolol, and their combination.

Authors:  M E Ring; J J Corrigan; P E Fenster
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

5.  The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.

Authors:  I Keber; M Jerse; D Keber; M Stegnar
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

6.  Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.

Authors:  A Joseph; J D Talley; A Shih; T Crum; R Vogel; J Kupersmith
Journal:  Int J Card Imaging       Date:  1994-09

7.  Effect of propranolol on platelet signal transduction.

Authors:  D Dash; K Rao
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

8.  Platelet reactivity and its dependence on alpha-adrenergic receptor function in patients with ischaemic heart disease.

Authors:  M Yokoyama; S Kawashima; S Sakamoto; H Akita; T Okada; T Mizutani; H Fukuzaki
Journal:  Br Heart J       Date:  1983-01

9.  Inhibition of adrenaline-induced platelet aggregation by the orally administered alpha-adrenergic receptor blocker phentolamine (Regitine).

Authors:  B Pfister; P R Imhof
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

10.  The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.

Authors:  M Luque Otero; C Fernandez Pinilla; A Escriba Polo; M Rodriguez Vazquez; N Martell Claros; A Fernandez-Cruz
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.